TREA

90459476 - POWERING THE FUTURE OF IMMUNE MEDICINE.

Follow

Information

  • Trademark
  • 90459476
  • Serial Number
    90459476
  • Filing Date
    January 11, 2021
    3 years ago
  • Transaction Date
    January 29, 2024
    11 months ago
  • Status Date
    June 05, 2023
    a year ago
  • Published for Opposition Date
    September 07, 2021
    3 years ago
  • Location Date
    November 02, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    MICHELI, ANGELA M
  • Attorney Docket Number
    10214-00502-
    Attorney Name
    Hoang-chi Truong
    Law Office Assigned Location Code
    L10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
POWERING THE FUTURE OF IMMUNE MEDICINE.
Case File Statements
  • GS0441: Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; Medical analysis services relating to the diagnosis and treatment of person
  • GS0421: Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
Case File Event Statements
  • 6/5/2023 - a year ago
    22 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 6/5/2023 - a year ago
    21 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 11/4/2022 - 2 years ago
    20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/2/2022 - 2 years ago
    19 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 11/2/2022 - 2 years ago
    18 - SOU EXTENSION 2 FILED Type: EXT2
  • 11/2/2022 - 2 years ago
    17 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/4/2022 - 2 years ago
    16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/2/2022 - 2 years ago
    15 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 5/2/2022 - 2 years ago
    14 - SOU EXTENSION 1 FILED Type: EXT1
  • 5/2/2022 - 2 years ago
    13 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/2/2021 - 3 years ago
    12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/7/2021 - 3 years ago
    11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/7/2021 - 3 years ago
    10 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/18/2021 - 3 years ago
    9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/2/2021 - 3 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/28/2021 - 3 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/28/2021 - 3 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/28/2021 - 3 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/28/2021 - 3 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/20/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/11/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/14/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP